Complications and Clinical Outcomes of Anterior Lumbar Interbody Fusion in Patients With Primary Hypercoagulable Disorders
Open Access
- 4 February 2025
- journal article
- Published by SAGE Publications in Global Spine Journal
- Vol. 15 (6) , 2931-2937
Abstract
Study Design: Retrospective cohort study. Objectives: To evaluate the complications of anterior lumbar interbody fusion (ALIF) in patients with primary hypercoagulable disorders and to compare outcomes between anterior and posterior spine fusions in this patient population. Methods: The PearlDiver national patient database was queried for patients with primary hypercoagulable disorders who underwent ALIF. Primary endpoints included the prevalence of hypercoagulable disorders in patients who underwent ALIF, incidence of perioperative anticoagulation utilization, as well as the 30-day risks of postoperative complications, readmissions, and revision surgeries. Multivariate regression analysis was conducted to compare outcomes between hypercoagulable patients and non-hypercoagulable patients undergoing ALIF and between hypercoagulable patients undergoing anterior vs posterior lumbar fusion. Results: Of the 211,390 patients who underwent ALIF, 3380 (1.60%) had a hypercoagulable disorder, with only 6.72% receiving perioperative anticoagulation. Within 30 days of ALIF, hypercoagulable disorders were identified as independent risk factors for hospital readmissions and both medical and surgical complications. Compared to posterior spine fusions, the anterior approach poses a greater risk for complications in this patient population. Conclusions: Patients with hypercoagulable disorders undergoing ALIF are at increased risk for readmissions and postoperative complications compared to those with normal coagulation profiles. While the posterior approach may be a safer option in this patient population, further research is needed to clarify the safest surgical approach for this high-risk population.Keywords
This publication has 20 references indexed in Scilit:
- The Effect of Coagulopathies on Perioperative Complications and Clinical Outcomes in Patients Treated With Posterior Lumbar FusionsSpine, 2016
- Prevalence and Risk Factors for Development of Venous Thromboembolism After Degenerative Spinal SurgerySpine, 2015
- The association of factor V Leiden with various clinical patterns of venous thromboembolism--the factor V Leiden paradoxQJM: An International Journal of Medicine, 2014
- Parenteral AnticoagulantsChest, 2012
- Does Preoperative DVT Chemoprophylaxis in Spinal Surgery Affect the Incidence of Thromboembolic Complications and Spinal Epidural Hematomas?Journal of Spinal Disorders & Techniques, 2011
- The timing of drug administration for thromboprophylaxis following orthopaedic surgery: evidence and controversies related to treatment initiation and duration.Current Vascular Pharmacology, 2011
- Factor V Leiden thrombophiliaGenetics in Medicine, 2011
- An evidence-based clinical guideline for the use of antithrombotic therapies in spine surgeryThe Spine Journal, 2009
- Postoperative Spinal Epidural Hematoma: Risk Factor and Clinical OutcomeYonsei Medical Journal, 2006
- Epidemiology of Factor V Leiden: Clinical ImplicationsSeminars in Thrombosis and Hemostasis, 1998